Overview
Gene therapy is a therapeutic strategy that treats disease by introducing, correcting, silencing, or replacing genetic material within a patient's cells. Rather than addressing symptoms alone, it targets the underlying molecular defect, whether by supplying a functional copy of a gene, editing a pathogenic sequence, or suppressing the activity of a harmful transcript. Approaches are commonly grouped by mechanism and delivery: gene addition, gene editing using tools such as CRISPR, and RNA-based silencing through small interfering RNA, alongside the viral and non-viral vectors, including nanoparticle carriers, used to reach target tissues. The field spans a broad range of conditions. Investigators explore correction of inherited metabolic and lysosomal storage disorders, modulation of coagulation factor deficiencies, and intervention in cardiovascular and metabolic disease, while in oncology efforts focus on the somatic alterations and signaling pathways that drive tumor growth. Effective gene therapy depends on precise targeting, durable and regulated expression, and acceptable safety, and its development draws on genomic and proteomic characterization of disease mechanisms and candidate genes. The discipline also raises distinctive ethical considerations regarding germline modification, access, and the boundaries of genetic medicine. As delivery and editing technologies mature, gene therapy continues to move from proof of concept toward durable, mechanism-based treatment of previously intractable disorders.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Type-2 Diabetes and Gene Therapy: The Promise of CRISPR Gene Therapy in type-2 Diabetes Mellitus
The Identification of Somatic Mutations in Interferon-G Signal Molecules in Human Uterine Leiomyosarcoma
Tay-Sachs Disease: From Molecular Characterization to Ethical Quandaries and the Possibility of Genetic Medicine
Evaluating the Efficacy of Gene Silencing in Dopaminergic Neuronal Cells In-Vitro using Gold Nanorods (GNR) with Different Surface Properties Complexed to DARPP-32 siRNA.
The Evolution of Fetal Surgery
Understanding Inherited Bleeding Disorders: Genetic Mutations in Blood Coagulation Factors and Regulatory Proteins
Molecular and Metabolic Pathogenesis of Familial Combined Hyperlipidemia and Association with Metabolic Syndrome
Some Regulation Mechanisms of Candidate Genes for Human Cardiovascular Diseases
Proteomic and Genomic Techniques in Medical Research: Applications in Cancer, Diagnostics, and Personalized Medicine
The Current Immunoassays and Emerging Immunogenomic Approaches for Immunomonitoring Cancer and Infectious Diseases
Dynamic MicroRNA-Expression in Plasma of Melanoma Patients Correlates With Progression, PD-L1 Status and Overall Survival
How this research is being cited
The 12 articles above have been cited 19 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · Human Gene
-
2024 · medRxiv (Cold Spring Harbor Laboratory)
-
2024 · Cytotherapy
-
Hongjun Wang et al. · 2024 · Cytotherapy
-
2024 · Current Diabetes Reviews
-
2023 · Current Diabetes Reviews
-
CFTR-mediated monocyte/macrophage dysfunction revealed by cystic fibrosis proband-parent comparisons2022 · JCI Insight
-
2022 · Research Square (Research Square)
A sample of recent works citing this journal's research on Gene Therapy, linking to each citing work.